We did, however, find a moderate to strong correlation (Spearman’s Rho = 0.61) between the BC-CCS and the C19orf57 gene in Groups 1 and 2, and a moderate one (Spearman’s Rho = 0.32) in the rest of the pan-cancer cohort. The gene discussed is BRME1; the disease is breast cancer.